<?xml version="1.0" encoding="UTF-8"?>
<ref id="onco13337-bib-0010">
 <label>10</label>
 <mixed-citation publication-type="journal" id="onco13337-cit-0010">
  <string-name>
   <surname>Blankenship</surname>
   <given-names>K.</given-names>
  </string-name>
  <article-title>Are IL‐6 inhibitors one key to COVID‐19? EUSA Pharma joins Sanofi</article-title>, 
  <source xml:lang="en">Regeneron in rolling out trials.</source> Available at 
  <ext-link ext-link-type="uri" xlink:href="https://www.fiercepharma.com/pharma/are-il-6-inhibitors-key-to-covid19-eusa-pharma-joins-sanofi-regeneron-rolling-out-trials" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fiercepharma.com/pharma/are‐il‐6‐inhibitors‐key‐to‐covid19‐eusa‐pharma‐joins‐sanofi‐regeneron‐rolling‐out‐trials</ext-link>. Accessed April 10, 2020.
 </mixed-citation>
</ref>
